Pathstone Holdings’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,855
Closed -$335K 2267
2025
Q3
$335K Buy
26,855
+4,960
+23% +$50.8K ﹤0.01% 1981
2025
Q2
$224K Hold
21,895
﹤0.01% 2025
2025
Q1
$173K Sell
21,895
-9,342
-30% -$115K ﹤0.01% 2103
2024
Q4
$245K Buy
31,237
+4,749
+18% +$23.8K ﹤0.01% 2064
2024
Q3
$83.4K Sell
26,488
-9,242
-26% -$27.2K ﹤0.01% 2254
2024
Q2
$101K Sell
35,730
-4,770
-12% -$34K ﹤0.01% 2224
2024
Q1
$638K Buy
40,500
+5,973
+17% +$101K ﹤0.01% 1558
2023
Q4
$681K Buy
+34,527
New +$600K ﹤0.01% 1314

Other funds holding CRNC

Pathstone Holdings's CRNC Position: Q4 2025 in Review

Pathstone Holdings sold out of Cerence (CRNC) in Q4 2025, closing a stake of 26,855 shares — an estimated $335K sold.

Pathstone Holdings first reported a position in CRNC in Q4 2023 and held it in 8 quarters. The position peaked at $681K in Q4 2023. 197 funds tracked by Wall St. Rank hold CRNC as of Q4 2025.

  • Pathstone Holdings reported no remaining Cerence position as of Q4 2025 after selling out during the quarter.
  • Pathstone Holdings sold 26,855 Cerence shares in Q4 2025, an estimated $335K.
  • Pathstone Holdings first reported a position in Cerence in Q4 2023 and held it in 8 quarters.
  • Pathstone Holdings's Cerence position peaked at $681K in Q4 2023.
  • 197 funds tracked by Wall St. Rank held Cerence as of Q4 2025.

Based on Pathstone Holdings's 13F filing for Q4 2025, filed 13 Feb 2026.